Amy E. Anderson

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Autoreactivity Versus Autoimmunity: Characteristics of Autoantigen-Specific CD4 T Cells in Rheumatoid Arthritis and Health.

Autoreactivity Versus Autoimmunity: Characteristics of Autoantigen-Specific CD4 T Cells in Rheumatoid Arthritis and Health.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: October 06, 2025

Human tolerogenic dendritic cell subtypes exert divergent effects on induction of cytotoxic CD4+ T cells.

Human tolerogenic dendritic cell subtypes exert divergent effects on induction of cytotoxic CD4+ T cells.

Journal: Frontiers in immunology

Published: September 03, 2025

Skeletal muscle effects of Janus kinase inhibition in rheumatoid arthritis (RAMUS): a single-arm, experimental medicine study.

Skeletal muscle effects of Janus kinase inhibition in rheumatoid arthritis (RAMUS): a single-arm, experimental medicine study.

Journal: The Lancet. Rheumatology

Published: April 14, 2025

Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study.

Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study.

Journal: BMJ open

Published: April 09, 2025

PEPITEM Regulates the Synovial Microenvironment During Immune-Mediated Inflammatory Arthritis to Limit Disease.

PEPITEM Regulates the Synovial Microenvironment During Immune-Mediated Inflammatory Arthritis to Limit Disease.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 19, 2025

Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis-2 (AuToDeCRA-2) study: protocol for a single-centre, experimental medicine study investigating the route of delivery and potential efficacy of autologous tolerogenic dendritic cell (TolDC) therapy for rheumatoid arthritis.

Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis-2 (AuToDeCRA-2) study: protocol for a single-centre, experimental medicine study investigating the route of delivery and potential efficacy of autologous tolerogenic dendritic cell (TolDC) therapy for rheumatoid arthritis.

Journal: Trials

Published: March 13, 2025

Intra-articular injection of autologous tolerogenic dendritic cells modifies the synovial immune landscape in rheumatoid and inflammatory arthritis.

Intra-articular injection of autologous tolerogenic dendritic cells modifies the synovial immune landscape in rheumatoid and inflammatory arthritis.

Journal: Annals of the rheumatic diseases

Published: February 13, 2025

Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis.

Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis.

Journal: RMD open

Published: January 09, 2025

Speech therapy for people with Parkinson's disease.

Speech therapy for people with Parkinson's disease.

Journal: BMJ (Clinical research ed.)

Published: July 10, 2024

Endogenous Retroelement Activation is Implicated in Interferon-α Production and Anti-Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis.

Endogenous Retroelement Activation is Implicated in Interferon-α Production and Anti-Cyclic Citrullinated Peptide Autoantibody Generation in Early Rheumatoid Arthritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 14, 2024

Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study.

Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study.

Journal: BMC cancer

Published: November 27, 2023

Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritis.

Adenosine metabolic signature in circulating CD4+ T cells predicts remission in rheumatoid arthritis.

Journal: RMD open

Published: October 30, 2023

Showing 1-12 of 49

Last Updated: 09/26/2026